|
Market Closed -
NYSE
21:00:03 10/06/2026 BST
|
5-day change
|
1st Jan Change
|
|
348.99 USD
|
-2.47%
|
|
-0.93%
|
+15.97%
|
|
05-19 |
Loop Capital Initiates Corpay at Buy With $406 Price Target
|
MT
| |
05-15 |
Autonomous Research Adjusts Price Target on Corpay to $392 From $366, Maintains Outperform Rating
|
MT
| |
05-08 |
JPMorgan Adjusts Corpay Price Target to $400 From $390
|
MT
| |
05-08 |
Morgan Stanley Adjusts Price Target on Corpay to $400 From $390
|
MT
| |
04-28 |
Morgan Stanley Lifts Corpay Price Target to $390 From $379, Maintains Overweight Rating
|
MT
| |
04-23 |
Raymond James Adjusts Corpay Price Target to $390 From $361, Maintains Outperform Rating
|
MT
| |
04-20 |
Autonomous Research Adjusts Price Target on Corpay to $366 From $371, Maintains Outperform Rating
|
MT
| |
04-15 |
WEX, Corpay Poised for Q1 Lift From Higher Fuel-Transaction Revenue, BofA Says
|
MT
| |
03-31 |
Baird Adjusts Price Target on Corpay to $380 From $440, Maintains Outperform Rating
|
MT
| |
03-20 |
Autonomous Research Adjusts Price Target on Corpay to $371 From $402, Maintains Outperform Rating
|
MT
| |
02-11 |
Autonomous Research Adjusts Corpay PT to $402 From $389, Maintains Outperform Rating
|
MT
| |
02-10 |
UBS Adjusts Price Target on Corpay to $380 From $315, Maintains Neutral Rating
|
MT
| |
02-06 |
Autonomous Research Adjusts Price Target on Corpay to $389 From $380, Maintains Outperform Rating
|
MT
| |
02-06 |
Mizuho Adjusts Price Target on Corpay to $340 From $320, Maintains Neutral Rating
|
MT
| |
02-05 |
Oppenheimer Adjusts Price Target on Corpay to $378 From $369, Maintains Outperform Rating
|
MT
| |
02-05 |
Raymond James Adjusts Price Target on Corpay to $361 From $347, Maintains Outperform Rating
|
MT
| |
02-05 |
JPMorgan Adjusts Price Target on Corpay to $390 From $350, Maintains Overweight Rating
|
MT
| |
02-05 |
RBC Raises Price Target on Corpay to $363 From $344, Keeps Sector Perform Rating
|
MT
| |
01-27 |
Cantor Fitzgerald Initiates Corpay at Overweight With $385 Price Target
|
MT
| |
01-26 |
Corpay's Multiple Catalysts Could Sustain Earnings Growth, Morgan Stanley Says
|
MT
| |
01-26 |
Morgan Stanley Upgrades Corpay to Overweight From Equalweight, Raises Price Target to $379 From $322
|
MT
| |
01-21 |
Jefferies Adjusts Price Target on Corpay to $370 From $335, Maintains Buy Rating
|
MT
| |
01-12 |
Oppenheimer Adjusts Corpay Price Target to $369 From $380, Maintains Outperform Rating
|
MT
| |
01-08 |
Wolfe Adjusts Price Target on Corpay to $375 From $350, Maintains Outperform Rating
|
MT
| |
12-18 |
Autonomous Research Lowers Corpay Price Target to $380 From $387, Maintains Outperform Rating
|
MT
|
No results match your criteria
Select your edition All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
|